PhantomX’s expertise in AI validation perfectly complements IBA’s portfolio of Clinical Workflow Solutions in Radiation Therapy and Medical Imaging,” said Jean-Marc Bothy, President of IBA Dosimetry
The Dosimetry/QA segment is relatively small compared to IBA’s total business. Thou this segment has higher margin potential (software/services, QA equipment) and contribute to recurring revenue (services, upgrades)
Other segments of IBA expected to benefit from this acquisition as wel.